CBLL — Ceribell, Inc.
Price · 2024-10-11 → 2026-08-21
466 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-10-11.
Performance
Technicals
Others in Healthcare
Measured signals that fired on CBLL
| date | signal | measured base rate |
|---|---|---|
| 2026-08-17 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-08-14 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-30 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-05-26 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Open-market sale 10b5-1 plan | 33.5K | 25.03 | 838.8K |
| 2026-08-19 | Chao Xingjuan President and CEO | Open-market sale 10b5-1 plan | 31.4K | 25.03 | 786.3K |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 plan | 27.3K | 9.41 | 257.2K |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 plan | 6.2K | 4.70 | 29.0K |
| 2026-08-18 | Chao Xingjuan President and CEO | Open-market sale 10b5-1 plan | 2.2K | 25.00 | 55.0K |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Open-market sale 10b5-1 plan | 990 | 25.00 | 24.8K |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 plan | 690 | 4.70 | 3.2K |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 plan | 300 | 9.41 | 2.8K |
| 2026-08-13 | Taylor Joseph Michael Director | Open-market sale | 13.1K | 23.40 | 306.4K |
| 2026-08-13 | Chao Xingjuan President and CEO | Option exercise | 25.0K | 3.65 | 91.2K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| FMR LLC | 88.9M | 4.9M |
| TPG GP A, LLC | 72.7M | 4.0M |
| RED TREE MANAGEMENT, LLC | 40.4M | 2.2M |
| BlackRock, Inc. | 33.2M | 1.8M |
| KCM Capital Inc | 25.7M | 1.4M |
| Bank of New York Mellon Corp | 21.3M | 1.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 20.8M | 1.1M |
| FEDERATED HERMES, INC. | 17.2M | 939.5K |
| FRANKLIN RESOURCES INC | 14.8M | 809.5K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 13.9M | 756.8K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 4 | 2026-08-20 | 2026-08-18 | on EDGAR ↗ |
| 4/A | 2026-08-20 | 2025-11-20 | on EDGAR ↗ |
| 4 | 2026-08-20 | 2026-08-18 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Ceribell, Inc. (CBLL) filed form 144 · 2026-08-21 · SEC EDGAR
- Ceribell, Inc. (CBLL) filed form 144 · 2026-08-21 · SEC EDGAR
- Ceribell, Inc. (CBLL) filed form 144 · 2026-08-21 · SEC EDGAR
- Ceribell, Inc. (CBLL) filed form 144 · 2026-08-21 · SEC EDGAR
- Ceribell, Inc. (CBLL) filed form 144 · 2026-08-21 · SEC EDGAR
- Ceribell expects $114M-$117M 2026 revenue as CMS finalizes delirium NTAP up to $2,171 per patient · 2026-08-11
Ask the AI about CBLL
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →